Stay updated on AK120 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the AK120 in Atopic Dermatitis Clinical Trial page.

Latest updates to the AK120 in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434 and links to updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check45 days agoChange DetectedA 403 Forbidden error page appears when attempting to view the study record, with the site's header and footer visible, indicating access restriction rather than a content update.SummaryDifference20%

- Check52 days agoChange DetectedAdded a Related topics section featuring Atopic dermatitis and MedlinePlus Genetics, providing quick access to related information.SummaryDifference0.2%

Stay in the know with updates to AK120 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK120 in Atopic Dermatitis Clinical Trial page.